These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 19465904)
21. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma. Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339 [TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697 [TBL] [Abstract][Full Text] [Related]
23. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Kaposi-Novak P; Libbrecht L; Woo HG; Lee YH; Sears NC; Coulouarn C; Conner EA; Factor VM; Roskams T; Thorgeirsson SS Cancer Res; 2009 Apr; 69(7):2775-82. PubMed ID: 19276364 [TBL] [Abstract][Full Text] [Related]
24. Morphological changes of early human hepatocarcinogenesis. Hytiroglou P Semin Liver Dis; 2004 Feb; 24(1):65-75. PubMed ID: 15085487 [TBL] [Abstract][Full Text] [Related]
25. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt. Hussein MR Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504 [TBL] [Abstract][Full Text] [Related]
26. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma. Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958 [TBL] [Abstract][Full Text] [Related]
28. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Tornillo L; Carafa V; Sauter G; Moch H; Minola E; Gambacorta M; Vecchione R; Bianchi L; Terracciano LM Lab Invest; 2002 May; 82(5):547-53. PubMed ID: 12003995 [TBL] [Abstract][Full Text] [Related]
29. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044 [TBL] [Abstract][Full Text] [Related]
30. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Plentz RR; Caselitz M; Bleck JS; Gebel M; Flemming P; Kubicka S; Manns MP; Rudolph KL Hepatology; 2004 Jul; 40(1):80-6. PubMed ID: 15239089 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma. Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617 [TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells. Shiu TY; Huang SM; Shih YL; Chu HC; Chang WK; Hsieh TY PLoS One; 2013; 8(4):e61089. PubMed ID: 23577194 [TBL] [Abstract][Full Text] [Related]
34. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097 [TBL] [Abstract][Full Text] [Related]
35. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature. van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986 [TBL] [Abstract][Full Text] [Related]
36. NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21 Williams M; Liu X; Zhang Y; Reske J; Bahal D; Gohl TG; Hollern D; Ensink E; Kiupel M; Luo R; Das R; Xiao H Oncogene; 2020 May; 39(19):3821-3836. PubMed ID: 32203160 [TBL] [Abstract][Full Text] [Related]
37. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells]. Lv BH; Zhang L; Zhu CC; Liu J Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303 [TBL] [Abstract][Full Text] [Related]
38. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Kwon Y; Lee SK; Kim JS; Ro JY; Yu E Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757 [TBL] [Abstract][Full Text] [Related]
39. Cause-specific telomere factors deregulation in hepatocellular carcinoma. El Idrissi M; Hervieu V; Merle P; Mortreux F; Wattel E J Exp Clin Cancer Res; 2013 Sep; 32(1):64. PubMed ID: 24020493 [TBL] [Abstract][Full Text] [Related]
40. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]